Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein αI-mediated activation of phosphotyrosine phosphatase

Endocrinology

Volumn 142, Issue 6, 2001, Pages 2369-2380

  Gründker, Carsten ^a   Völker, Peter ^a   Emons, Günter ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Dept of Gynecology and Obstetrics ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GONADORELIN; GONADORELIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; AUTOPHOSPHORYLATION; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; DNA SEQUENCE; ENDOMETRIUM CANCER; ENZYME ACTIVATION; HORMONE ACTION; HUMAN; HUMAN CELL; MITOGENESIS; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0035020249     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.6.8190     Document Type: Article

References (46)

1. 1. Conn PM, Crowley Jr WF 1991 Gonadotropin-releasing hormone and its analogues. N Engl J Med 324:93-103
2. 2. Schally AV 1994 Hypothalamic hormones from neuroendocrinology to cancer therapy. Anticancer Drugs 5:15-130
3. 3. Shupnik MA 1996 Gonadotropin gene modulation by steroids and gonadotropin-releasing hormone. Biol Reprod 54:279-286
4. 11. Mol Endocrinol 6:1673-1681
5. 5. Stojilkovic SS, Catt KJ 1995 Expression and signal transduction pathways of gonadotropin-releasing hormone receptors. Recent Prog Horm Res 30:161-205
6. 2+ and protein kinase C. Front Neuroendocrinol 19:1-9
7. 7. Kakar SS, Jennes L 1995 Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues. Cancer Lett 98:57-62
8. 8. Lin LS, Roberts VJ, Yen SS 1995 Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J Clin Endocrinol Metab 80:580-585
9. 9. Minaretis D, Jakubowski M, Mortola JF, Pavlou SN 1995 Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosalutein cells. J Clin Endocrinol Metab 80:430-434
10. 10. Chegini N, Rong H, Dou Q, Kipersztok S, Williams RS 1996 Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro. J Clin Endocrinol Metab 81:3215-3221
11. 11. Emons G, Ortmann O, Schulz KD, Schally AV 1997 Growth-inhibitory actions of luteinizing hormone releasing hormone on tumor cells. Trends Endocrinol Metab 8:355-362
12. 12. Emons G, Weiss S, Ortmann O, Gründker C, Schulz KD 2000 Luteinizing hormone-releasing hormone (LHRH) might act as a negative autocrine regulator of proliferation of human ovarian cancer. Eur J Endocrinol 142:665-670
13. 6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer. Int J Oncol 12:489-498
14. 14. Chatzaki E, Bax CMR, Eidne KA, Anderson L, Grudzinskas JG, Gallagher CJ 1996 The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer and its relevance as an autocrine growth factor. Cancer Res 56:2055-2065
15. 15. Yin H, Cheng KW, Hwa HL, Peng C, Auersperg N, Leung PC 1998 Expression of the mRNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines. Life Sci 62:2015-2023
16. 6]-luteinizing-hormone-releasing hormone, somatostatin, epidermal growth factor and sex steroids in 500 biopsy samples of human breast cancer. J Clin Lab Anal 3:137-147
17. 17. Shacham S, Cheifetz MN, Lewy H, Ashkenazi IE, Becker OM, Seger R, Naor Z 1999 Mechanism of GnRH receptor signaling: from the membrane to the nucleus. Ann Endocrinol (Paris) 60:79-88
18. 18. Emons G, Müller V, Ortmann O, Grossmann G, Trautner U, von Stuckrad B, Schulz KD, Schally AV 1996 Luteinizing hormone-releasing hormone agonist triptorelin antagonizes signal transduction and mitogenic activity of epidermal growth factor in human ovarian and endometrial cancer cell lines. Int J Oncol 9:1129-1137
19. 19. Gründker C, Völker P, Schulz KD, Emons G 2000 Luteinizing hormone-releasing hormone (LHRH) agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers. Gynecol Oncol 78:194-202
20. 318 mutations on ligand binding and signal transduction in the rat GnRH receptor. J Endocrinol 139:R1-R4
21. 21. Zhou W, Flanagan C, Ballesteros JA, Konvicka K, Davidson JS, Weinstein H, Millar RP, Sealfon SC 1994 A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol 45:165-170
22. 22. Davidson JS, Flanagan CA, Zhou W, Becker II, Elario R, Emeran W, Sealfon SC, Millar RP 1995 Identification of N-glycosylation sites in the gonadotropin-releasing homone receptor: role in receptor expression but not ligand binding. Mol Cell Endocrinol 107:241-245
23. 23. Fan NC, Peng C, Krisinger J, Leung PC 1995 The human gonadotropin-releasing hormone receptor gene: complete structure including multiple promotors, transcription initiation sites, and polyadenylation signals. Mol Cell Endocrinol 107:R1-R8
24. 24. Sharif M, Sasakawa N, Hanley MR 1994 Malignant transformation by G protein-coupled hormone receptors. Mol Cell Endocrinol 100:115-119
25. 25. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA 1994 Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101-132
26. 26. Kottler ML, Bergametti F, Carre MC, Morice S, Decoret E, Lagarde JP, Starzec A, Counis R 1999 Tissue-specific pattern of variant transcripts of the human gonadotropin-releasing hormone receptor gene. Eur J Endocrinol 140:561-569
27. 27. Imai A, Takagi H, Furui T, Horibe S, Fuseya T, Tamaya T 1996 Evidence for coupling of phosphotyrosine phosphatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane. Cancer 77:132-137
28. 28. Nishida M, Kasahara K, Kaneko M, Iwasaki H 1985 Establishment of a new endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynaec Jpn 37:1103-1111
29. 29. Kuramoto H, Tamura S, Notake Y 1972 Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am J Obstet Gynecol 144:1012-1019
30. 30. Simon WE, Albrecht M, Hänsel M, Dietel M, Hölzel F 1983 Cell lines derived from human ovarian carcinomas; growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 70:839-845
31. 31. Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Hölzel F, Schulz KD, Schally AV 1993 High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res 54:5439-5446
32. 32. Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD 1992 Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnKH) receptor. Biochem Biophys Res Commun 189:289-295
33. 33. Harder KW, Owen P, Wong LK, Aebersold R, Clark-Lewis I, Jirik FR 1994 Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase β (HPTPβ) using synthetic phosphopeptides. Biochem J 298:395-401
34. 34. Daum G, Solca F, Diltz CD, Zhao Z, Cool DE, Fischer EH 1993 A general peptide substrate for protein tyrosine phosphatases. Anal Biochem 211:50-54
35. 35. Emons G, Müller V, Ortmann O, Schulz KD 1998 Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. J Steroid Biochem Mol Biol 65:199-206
36. 36. Emons G, Schröder B, Ortmann O, Westphalen S, Schulz KD, Schally AV 1993 High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab 77:1458-1464
37. 37. Deleted in proof
38. 38. Moretti RM, Montagnani-Marelli M, Dondi D, Poletti A, Martini L, Motta M, Limonta P 1996 Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145. J Clin Endocrinol Metab 81:3930-3937
39. 39. Kakar SS, Grizzle WE, Neill JD 1994 The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol Cell Endocrinol 106:145-149
40. i protein in human reproductive tract tumors. J Clin Endocrinol Metab 81:3249-3253
41. 41. Gründker C, Schulz K, Günthert AR, Emons G 2000 Luteinizing hormone-releasing hormone induces nuclear factor κB-activation and inhibits apoptosis in ovarian cancer cells. J Clin Endocrinol Metab 85:3815-3820
42. 42. Limonta P, Moretti RM, Montagnani-Marelli M, Dondi D, Parenti M, Motta M 1999 The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway. Endocrinology 140:5250-5256
43. 3 cells: evidence from palmitoylation and overexpression of G-proteins. Biol Reprod 59:579-586
44. 44. Schwindinger WF, Fredericks J, Watkins L, Robinson H, Bathon JM, Pines M, Suva LJ, Levine MA 1998 Coupling of the PTH/PTHrP receptor to multiple G-proteins. Endocrine 8:201-209
45. 45. Biebermann H, Schöneberg T, Schulz A, Krause G, Grüters A, Schultz G, Gudermann T 1998 A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB J 12:1461-1471
46. 46. Grosse R, Schmid A, Schöneberg T, Herrlich A, Muhn P, Schultz G, Gudermann T 2000 Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by excusively coupling to G (q/11) proteins. J Biol Chem 275:9193-9200